9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Helen R. Warren(Queen Mary University of London), Michael Golatta(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Marjanka K. Schmidt(University of Cambridge), Frederik Marmé(Heidelberg University), Claire Mulot(Inserm), Peter A. Fasching(Universitätsklinikum Erlangen), Anne Langheinz(Institute of Cancer Research), Frank Dudbridge(University of Cambridge), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Kenneth Muir(Manchester Academic Health Science Centre), Linda M. Braaf(Institute of Cancer Research), Pascal Guénel(Inserm), José-Ignacio Arias-Pérez(Institute of Cancer Research), Ian Tomlinson(University of Oxford), Roger L. Milne(The University of Melbourne), Sten Cornelissen, Arif B. Ekici(University Medical Center Groningen), Leslie Bernstein(National Cancer Institute), Javier Benı́tez(Spanish National Cancer Research Centre), Henrik Flyger(University of Copenhagen), Surapon Wiangnon(Institute of Cancer Research), Elinor J. Sawyer(King's College London), Heiko Müller(Munich Leukemia Laboratory (Germany)), Christina Clarke Dur(Cancer Prevention Institute of California), Olivia Fletcher(Breast Cancer Care), Argyrios Ziogas(University of Copenhagen), Nick Orr(United States Department of Health and Human Services), Stig E. Bojesen(University of Copenhagen), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Børge G. Nordestgaard(Gentofte Hospital), Christof Sohn, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Pierre Laurent‐Puig(Inserm), R. Schulz-Wendtland(Universitätsklinikum Erlangen), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Artitaya Lophatananon(University of Warwick), Sune F. Nielsen(Herlev Hospital), Maryam Mahmoodi(Institute of Cancer Research), Carmel Apicella(The University of Melbourne), Arkom Chaiwerawattana(Institute of Cancer Research), Alfons Meindl(Helmholtz Zentrum München), Nichola Johnson(Institute of Cancer Research)
Cited by 18
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k